Ventas (NYSE:VTR) Updates FY 2026 Earnings Guidance

Ventas (NYSE:VTR) updated its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.850-3.900 for the period, compared to the consensus estimate of 3.880. The company issued revenue guidance of -.

Ventas Price Performance

Shares of NYSE:VTR traded up $0.67 during trading on Friday, reaching $92.93. The company had a trading volume of 576,123 shares, compared to its average volume of 3,662,434. Ventas has a twelve month low of $66.38 and a twelve month high of $101.60. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The firm has a market capitalization of $47.67 billion, a PE ratio of 172.08, a price-to-earnings-growth ratio of 2.14 and a beta of 0.69. The firm’s fifty day moving average is $89.32 and its 200 day moving average is $86.05.

Ventas Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.52 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. Ventas’s dividend payout ratio is currently 385.19%.

Analyst Ratings Changes

VTR has been the subject of a number of research analyst reports. Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, July 21st. JPMorgan Chase & Co. lifted their price target on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. Mizuho upped their price target on Ventas from $98.00 to $104.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. BMO Capital Markets reissued an “outperform” rating and issued a $100.00 price objective on shares of Ventas in a research note on Monday, May 4th. Finally, The Goldman Sachs Group restated a “buy” rating and set a $110.00 price objective on shares of Ventas in a research report on Tuesday, May 19th. Fifteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $97.56.

Insiders Place Their Bets

In related news, Director Michael J. Embler bought 2,500 shares of the business’s stock in a transaction on Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the sale, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Ventas

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Wiser Advisor Group LLC acquired a new stake in Ventas in the 3rd quarter valued at approximately $27,000. IFC & Insurance Marketing Inc. acquired a new position in Ventas during the 4th quarter valued at $30,000. Zions Bancorporation National Association UT raised its stake in Ventas by 250.3% during the 4th quarter. Zions Bancorporation National Association UT now owns 508 shares of the real estate investment trust’s stock valued at $39,000 after purchasing an additional 363 shares during the last quarter. DV Equities LLC bought a new stake in Ventas in the 4th quarter valued at $51,000. Finally, Rossby Financial LCC boosted its holdings in Ventas by 45.8% in the 4th quarter. Rossby Financial LCC now owns 729 shares of the real estate investment trust’s stock valued at $56,000 after purchasing an additional 229 shares during the period. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.